Who Owns BNGO?

Bionano Genomics, Inc. — Institutional Ownership & 13F Holdings

$1.24

+0.00 (+0.00%)

Market Cap

$3.7M

Shares Outstanding

3,283,411

Institutional Holders

30

Total Inst. Value

$1.3M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Everstar Asset Management, LLC$958K44,984
2VANGUARD GROUP INC$138K49,979
3JONES FINANCIAL COMPANIES LLLP$60K634
4GEODE CAPITAL MANAGEMENT, LLC$42K15,506
5MORGAN STANLEY$32K11,991
6BlackRock, Inc.$28K10,103
7BANK OF AMERICA CORP /DE/$23K8,393
8OSAIC HOLDINGS, INC.$9K3,208
9UBS Group AG$7K2,373
10GROUP ONE TRADING LLC$5K1,790

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold BNGO?

As of Q1 2025, 30 institutional investors report holding BNGO (Bionano Genomics, Inc.) in their 13F filings.

Which hedge fund owns the most BNGO?

The largest institutional holder of BNGO is Everstar Asset Management, LLC with $958K in shares.

Are institutions buying or selling BNGO?

This quarter, 28 institutions opened new positions in BNGO and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.